{"transactions":[{"id":746482,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T20:17:44.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":41600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":135069,"source":{"system":"sec-edgar","filing":"0001193125-26-261782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000119312526261782/ownership.xml","form_type":"4"}},{"id":885355,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T21:28:24.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":8.03,"value":240900.0,"ownership":{"direct":true},"balance_after":93469,"source":{"system":"sec-edgar","filing":"0001193125-26-067185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000119312526067185/ownership.xml","form_type":"4"}},{"id":1118266,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T21:34:48.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":59225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":123469,"source":{"system":"sec-edgar","filing":"0000950170-25-083885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000095017025083885/ownership.xml","form_type":"4"}},{"id":1507386,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-21T20:55:09.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":37578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":37578,"derivative":{"exercise_price":5.48,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":37578},"source":{"system":"sec-edgar","filing":"0000950170-24-063022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000095017024063022/ownership.xml","form_type":"4"}},{"id":1507385,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T20:55:09.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":20529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":64244,"source":{"system":"sec-edgar","filing":"0000950170-24-063022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000095017024063022/ownership.xml","form_type":"4"}},{"id":1859182,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T20:19:01.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":33960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":33960,"derivative":{"exercise_price":6.5,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":33960},"source":{"system":"sec-edgar","filing":"0001209191-23-036282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000120919123036282/doc4.xml","form_type":"4"}},{"id":1859181,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T20:19:01.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":17307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":43715,"source":{"system":"sec-edgar","filing":"0001209191-23-036282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000120919123036282/doc4.xml","form_type":"4"}},{"id":1947696,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-17T20:50:20.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":51276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests with respect to 25% of the underlying shares on March 15, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":51276,"derivative":{"exercise_price":6.39,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":51276},"source":{"system":"sec-edgar","filing":"0001209191-23-019714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000120919123019714/doc4.xml","form_type":"4"}},{"id":1947695,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40568,"kind":"person","name":"Honore Tage","position":1,"cik":"0001967946","reported_name":"Honore Tage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T20:50:20.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":26408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 15, 2024, provided the Reporting Person has provided continuous service through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":26408,"source":{"system":"sec-edgar","filing":"0001209191-23-019714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967946/000120919123019714/doc4.xml","form_type":"4"}}]}